- NCIt
- C6926
Loading cancer entity…
Loading cancer entity…
Clinical trials
26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04927260 | French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients(AVIATOR2020) | unknown | — | 25 | Centre Leon BerardOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 |
| clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT03171389 | POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST(POETIG) | unknown | Phase 2 | 81 | Sebastian BauerOTHER | 1 | May 31, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Dec 26, 2023source: clinicaltrials